Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) Operating Expenses (2023 - 2024)

Sagimet Biosciences (SGMT) has 2 years of Operating Expenses data on record, last reported at $18.2 million in Q4 2024.

  • For Q4 2024, Operating Expenses rose 92.21% year-over-year to $18.2 million; the TTM value through Dec 2024 reached $54.5 million, up 66.32%, while the annual FY2025 figure was $56.9 million, 4.47% up from the prior year.
  • Operating Expenses reached $18.2 million in Q4 2024 per SGMT's latest filing, up from $16.9 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $18.2 million in Q4 2024 and bottomed at $6.8 million in Q1 2023.